Clinical studies recruiting near Pisa

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Azienda Ospedaliera Universitaria Pisana · Eli Lilly and Company · NCT07218380 A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · Investigational Site Number : 3800004 · Sanofi · NCT06867094 A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 3 · Azienda Ospedaliero Universitaria Pisana · Takeda · NCT06747351 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Azienda Ospedaliero Universitaria Pisana · Bristol-Myers Squibb · NCT07106762 Spinocerebellar Ataxia Type 27B Natural History Study (SCA27B-NHS)
Phase N/A · IRCCS Fondazione Stella Maris · University Hospital Tuebingen · NCT06472557 A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Azienda Ospedaliero Universitaria Pisana · Bristol-Myers Squibb · NCT06929273 "Ultra-High Frequency intraOral UltraSonography of the TONgue" (HOUSTON)
NA · Università di Pisa · University of Pisa · NCT06336941 A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Phase 3 · Azienda Ospedaliero Universitaria Pisana - Stabilimento Sant · H. Lundbeck A/S · NCT05897320 STOP-HSP.Net: a Registry for Hereditary Spastic Paraplegia as an Integration Tool for Future Therapeutic Strategies
Phase N/A · IRCCS Fondazione Stella Maris · IRCCS Fondazione Stella Maris · NCT06572046 Ultra-High Frequency Ultrasonography in Sjögren's Syndrome
NA · University of Pisa · University of Pisa · NCT06338735 A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants Wit
Phase 1/Phase 2 · Local Institution - 0109 · Bristol-Myers Squibb · NCT07291076 Observational Study on Skeletal Ewing's Sarcoma
Phase N/A · Azienda Ospedaliero-Universitaria Pisana · Italian Sarcoma Group · NCT04845893 A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advance
Phase 1/Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT06885034 A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary
Phase N/A · Cisanello · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615 A Story for Pepper & Nao
NA · IRCCS Fondazione Stella Maris · NCT06797050 A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Pati
Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06581198 Registry for Patients With Lipodystrophy
Phase N/A · Endocrine Unit of University Hospital of Pisa · University of Ulm · NCT03553420 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 Identification of Neuroinflammation and Neuroimaging Biomarkers Through Data Driven Artificial Intelligence Techniques f
NA · Azienda Ospedaliera Universitaria Pisana · IRCCS Fondazione Stella Maris · NCT06746909 Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera
Phase 3 · Azienda Ospedaliero Universitaria Pisana · Eli Lilly and Company · NCT06937086 Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · A.O.U. Pisana, U.O. Epatologia · Gilead Sciences · NCT06051617 Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALS
Phase 2/Phase 3 · Azienda Ospedaliero Universitaria Pisana · Mario Negri Institute for Pharmacological Research · NCT06126315 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Azienda Ospedaliera Universitaria Pisana · Boehringer Ingelheim · NCT06531824 LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Phase 3 · Tenax Investigational Site · Tenax Therapeutics, Inc. · NCT07288398 Italian NCL Registry: a Registry for NCL as an Integration Tool for Future Therapeutic Strategies
Phase N/A · IRCCS Fondazione Stella Maris · IRCCS Fondazione Stella Maris · NCT06844877 ReModeling in ST-elevation myocARrdial Infarction: a Comparison of Left VEntricuLar Functions in Long-term Follow-up Amo
Phase N/A · University of Pisa, Cisanello Hospital · University of Pisa · NCT07041840 Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
Phase 2 · AOU Pisana · NMD Pharma A/S · NCT06414954 A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal
Phase 3 · Azienda Ospedaliero Universitaria Pisana - Stabilimento Sant · Eli Lilly and Company · NCT06338995 Arrhythmias Detection in a Real World Population
Phase N/A · Azienda Ospedaliero Universitaria Pisa Cisanello · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT02275637

Look up another city

Look up another condition